Galenica AG Share Price Deutsche Boerse AG

Equities

G70

CH0360674466

Pharmaceuticals

Market Closed - Deutsche Boerse AG 07:13:43 28/06/2019 pm IST 5-day change 1st Jan Change
43.98 EUR -0.50% Intraday chart for Galenica AG -.--% -.--%

Financials

Sales 2024 * 3.92B 4.34B 4B 363B Sales 2025 * 4.08B 4.52B 4.17B 377B Capitalization 3.72B 4.12B 3.8B 344B
Net income 2024 * 174M 193M 178M 16.09B Net income 2025 * 183M 203M 187M 16.93B EV / Sales 2024 * 1.09 x
Net Debt 2024 * 540M 598M 551M 49.93B Net Debt 2025 * 510M 565M 521M 47.17B EV / Sales 2025 * 1.04 x
P/E ratio 2024 *
21.6 x
P/E ratio 2025 *
20.3 x
Employees 6,181
Yield 2024 *
3.06%
Yield 2025 *
3.17%
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
5 years
43.02
Extreme 43.02
45.52
10 years
37.82
Extreme 37.82
52.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO 58 01/10/01
Chief Tech/Sci/R&D Officer 52 01/22/01
Members of the board TitleAgeSince
Chief Executive Officer 71 01/96/01
Director/Board Member 66 11/23/11
Director/Board Member 62 01/17/01
More insiders
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
74.7 CHF
Average target price
77 CHF
Spread / Average Target
+3.08%
Consensus